Summary:
- The National Institutes of Health (NIH) is launching a clinical trial to test precision medicine treatments for myeloid cancers, which are a group of blood and bone marrow cancers.
- The trial will evaluate the use of targeted therapies based on the genetic profiles of individual patients' cancers, aiming to improve outcomes for those with myeloid cancers.
- The study will enroll up to 1,000 adults with acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia, and match them with appropriate targeted therapies based on the genetic characteristics of their cancer.